| Primary |
| Antiplatelet Therapy |
22.0% |
| Thrombosis Prophylaxis |
10.1% |
| Cardiac Stress Test |
7.3% |
| Hypertension |
6.4% |
| Cardiac Failure |
5.5% |
| Cerebrovascular Disorder |
5.5% |
| Kawasaki's Disease |
5.5% |
| Diabetes Mellitus |
4.6% |
| Scintigraphy |
4.6% |
| Gastric Cancer |
3.7% |
| Transient Ischaemic Attack |
3.7% |
| Cerebral Infarction |
2.8% |
| Essential Hypertension |
2.8% |
| Investigation |
2.8% |
| Migraine |
2.8% |
| Prophylaxis |
2.8% |
| Angina Pectoris |
1.8% |
| Anticoagulant Therapy |
1.8% |
| Arrhythmia |
1.8% |
| Atrial Fibrillation |
1.8% |
|
| Subdural Haematoma |
8.5% |
| Cerebrovascular Accident |
6.4% |
| Thrombocytopenia |
6.4% |
| Tubulointerstitial Nephritis |
6.4% |
| Vomiting |
6.4% |
| White Blood Cell Count Decreased |
6.4% |
| Anaemia |
4.3% |
| Blood Pressure Decreased |
4.3% |
| Cerebral Haemorrhage |
4.3% |
| Death |
4.3% |
| Drug Intolerance |
4.3% |
| Extradural Haematoma |
4.3% |
| Hypersensitivity |
4.3% |
| Hypotension |
4.3% |
| Medication Error |
4.3% |
| Spinal Haematoma |
4.3% |
| Stomatitis |
4.3% |
| Supraventricular Tachycardia |
4.3% |
| Syncope |
4.3% |
| Transient Ischaemic Attack |
4.3% |
|
| Secondary |
| Product Used For Unknown Indication |
33.6% |
| Prophylaxis |
11.6% |
| Drug Use For Unknown Indication |
10.0% |
| Hypertension |
6.3% |
| Influenza |
4.7% |
| Systemic Lupus Erythematosus |
3.7% |
| Atrial Fibrillation |
3.3% |
| Cardiac Stress Test |
3.3% |
| Chest Pain |
3.3% |
| Hypercholesterolaemia |
3.3% |
| Transient Ischaemic Attack |
3.0% |
| Diarrhoea |
2.0% |
| Diabetes Mellitus |
1.7% |
| Henoch-schonlein Purpura |
1.7% |
| Pain |
1.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
| Asthma |
1.3% |
| Atherosclerosis Prophylaxis |
1.3% |
| Cellulitis |
1.3% |
| Depression |
1.3% |
|
| Vomiting |
14.3% |
| Pneumonia |
10.2% |
| Drug Hypersensitivity |
6.1% |
| Fall |
6.1% |
| Gastrointestinal Haemorrhage |
6.1% |
| Microcytic Anaemia |
6.1% |
| Pulmonary Haemorrhage |
6.1% |
| Toe Amputation |
6.1% |
| Cholelithiasis |
4.1% |
| Cystitis |
4.1% |
| Death |
4.1% |
| Rash |
4.1% |
| Renal Failure |
4.1% |
| Sick Sinus Syndrome |
4.1% |
| Thrombocytopenia |
4.1% |
| Confusional State |
2.0% |
| Contusion |
2.0% |
| Gastric Ulcer Haemorrhage |
2.0% |
| Hepatitis |
2.0% |
| Hepatitis Fulminant |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.2% |
| Hypertension |
18.6% |
| Product Used For Unknown Indication |
15.3% |
| Diabetes Mellitus |
4.2% |
| Angina Pectoris |
3.7% |
| Multiple Myeloma |
3.7% |
| Osteoporosis |
3.6% |
| Rheumatoid Arthritis |
3.4% |
| Renal Transplant |
3.2% |
| Nephrotic Syndrome |
2.5% |
| Pain |
2.4% |
| Parkinson's Disease |
2.3% |
| Coronary Artery Bypass |
2.1% |
| Glomerulonephritis Membranoproliferative |
2.1% |
| Systemic Lupus Erythematosus |
2.1% |
| Constipation |
2.0% |
| Hypercholesterolaemia |
2.0% |
| Hyperlipidaemia |
2.0% |
| Prophylaxis |
2.0% |
| Gastritis |
1.8% |
|
| Vomiting |
10.2% |
| Wound Drainage |
9.0% |
| Malaise |
6.0% |
| Weight Decreased |
6.0% |
| Myopathy |
5.4% |
| Pyrexia |
5.4% |
| Renal Failure |
5.4% |
| Renal Failure Acute |
5.4% |
| Death |
4.8% |
| Pneumonia |
4.2% |
| Somnolence |
4.2% |
| Transient Ischaemic Attack |
4.2% |
| Venous Thrombosis Limb |
4.2% |
| Pain |
3.6% |
| Renal Failure Chronic |
3.6% |
| Rhinorrhoea |
3.6% |
| Unresponsive To Stimuli |
3.6% |
| Urinary Tract Infection |
3.6% |
| Vision Blurred |
3.6% |
| White Blood Cell Count Increased |
3.6% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
|
